BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 33968899)

  • 1. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.
    Li Y; Yang J; Sun X
    Front Chem; 2021; 9():650587. PubMed ID: 33968899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Reactive Oxygen Species Generated by Inorganic Nanomaterials for Cancer Therapeutics.
    Zhang L; Zhu C; Huang R; Ding Y; Ruan C; Shen XC
    Front Chem; 2021; 9():630969. PubMed ID: 33816437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy.
    Wu M; Ding Y; Li L
    Nanoscale; 2019 Nov; 11(42):19658-19683. PubMed ID: 31612164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy.
    Gao Y; Tong H; Li J; Li J; Huang D; Shi J; Xia B
    Front Bioeng Biotechnol; 2021; 9():720508. PubMed ID: 34490227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer.
    Foglietta F; Serpe L; Canaparo R
    Discov Nano; 2023 Dec; 18(1):151. PubMed ID: 38078991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy.
    Liu P; Hao L; Liu M; Hu S
    Front Bioeng Biotechnol; 2023; 11():1161472. PubMed ID: 36970628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Nanodynamic Therapy for Cancer Treatment.
    Zhang B; Huang Y; Huang Y
    Nanomaterials (Basel); 2024 Apr; 14(7):. PubMed ID: 38607182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.
    Wu D; Chen X; Zhou S; Li B
    Front Immunol; 2023; 14():1241791. PubMed ID: 37731484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Biomedical Applications of Reactive Oxygen Species-Based Nanomaterials in Lung Cancer.
    Zhao N; Xin H; Zhang L
    Front Chem; 2021; 9():649772. PubMed ID: 33898390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy.
    Wang P; Liang C; Zhu J; Yang N; Jiao A; Wang W; Song X; Dong X
    ACS Appl Mater Interfaces; 2019 Nov; 11(44):41140-41147. PubMed ID: 31603650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy.
    Ni K; Lan G; Lin W
    ACS Cent Sci; 2020 Jun; 6(6):861-868. PubMed ID: 32607433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS-mediated Therapeutics Combined with Metal-based Porphyrin Nanoparticles and their Applications in Tumor Treatment.
    Yang L; Shi L; Liu Y; Liu Z; Tian Z; Li H; Zhang J; He J; Liu Y
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37859412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy.
    Hao YN; Zhang WX; Gao YR; Wei YN; Shu Y; Wang JH
    J Mater Chem B; 2021 Jan; 9(2):250-266. PubMed ID: 33237121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer therapy mediated by nanomedicines.
    Zhang S; Zhang H; Song P; Wang D; Wang Y
    Chem Commun (Camb); 2023 Apr; 59(30):4423-4435. PubMed ID: 36950975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy.
    Cao Z; Li D; Wang J; Yang X
    Acta Biomater; 2021 Aug; 130():17-31. PubMed ID: 34058390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer.
    Wang W; Jin Y; Xu Z; Liu X; Bajwa SZ; Khan WS; Yu H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1614. PubMed ID: 32011108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy.
    Zhong Y; Li X; Chen J; Wang X; Wei L; Fang L; Kumar A; Zhuang S; Liu J
    Dalton Trans; 2020 Aug; 49(32):11045-11058. PubMed ID: 32756684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment.
    Chen Q; Li N; Wang X; Yang Y; Xiang Y; Long X; Zhang J; Huang J; Chen L; Huang Q
    Front Pharmacol; 2022; 13():847048. PubMed ID: 35222052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy.
    Liang S; Deng X; Ma P; Cheng Z; Lin J
    Adv Mater; 2020 Nov; 32(47):e2003214. PubMed ID: 33064322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.